Published in Cancer Res on March 01, 1981
Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo. Br J Cancer (1989) 0.93
Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma. Br J Cancer (2003) 0.83
Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. Br J Cancer (1988) 0.83
Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo. Br J Cancer (1992) 0.80
Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123. J Clin Invest (1987) 0.75
Update in cancer chemotherapy: gastrointestinal cancer--colorectal cancer, Part 2. J Natl Med Assoc (1986) 0.75
Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Cancer Inst (1991) 3.07
Acute and nonacute complications associated with interscalene block and shoulder surgery: a prospective study. Anesthesiology (2001) 2.61
Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy (2001) 2.07
Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A (2010) 1.67
The relationship between juxtapapillary duodenal diverticula and disorders of the biliopancreatic system: analysis of 350 patients. Gastrointest Endosc (2001) 1.63
Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms. Gastrointest Endosc (1998) 1.60
Presentation and physical evaluation of RadioVisioGraphy. Oral Surg Oral Med Oral Pathol (1989) 1.58
Improved tumor staging by diagnostic laparoscopy. Z Gastroenterol (1999) 1.58
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol (2001) 1.48
Pancreatic endoscopic sphincterotomy in patients with chronic pancreatitis: a single-center experience in 171 consecutive patients. Endoscopy (2002) 1.47
Long-term follow-up of patients with iron deficiency anemia after a close endoscopic examination of the upper and lower gastrointestinal tract. Z Gastroenterol (2000) 1.41
Efficacy of intraoral topical anesthetics in children. J Dent (2005) 1.40
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene (1992) 1.34
A new HF current generator with automatically controlled system (Endocut mode) for endoscopic sphincterotomy--preliminary experience. Endoscopy (1998) 1.30
Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology (1997) 1.20
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol (1998) 1.19
A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell (2000) 1.16
Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J Biol Chem (1988) 1.15
An analysis of 1539 patients with cancer of unknown primary site. Cancer (1986) 1.11
Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. Science (1979) 1.11
Determination of protein by a modified Lowry procedure in the presence of some commonly used detergents. Anal Biochem (1979) 1.09
Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton. J Pharmacol Exp Ther (1997) 1.04
Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol (1997) 1.02
Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy. Dig Dis Sci (1997) 1.01
Electrohydraulic lithotripsy treatment of gallstone after disimpaction of the stone from the duodenal bulb (Bouveret's syndrome). Ital J Gastroenterol Hepatol (1999) 1.00
Survival of women with metastatic breast cancer at Yale from 1920 to 1980. J Clin Oncol (1983) 1.00
The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. J Biol Chem (1981) 0.97
Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay. J Clin Oncol (2001) 0.95
Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells. Cancer Res (1986) 0.94
Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate. Pharmacol Ther (1989) 0.92
Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res (1986) 0.91
Endoscopic biliary stenting for the palliation of pancreatic cancer: results, survival predictive factors, and comparison of 10-French with 11.5-French gauge stents. Am J Gastroenterol (1996) 0.91
Treatment of difficult intrahepatic stones by using extracorporeal and intracorporeal lithotripsy techniques: 10 years' experience in 55 patients. Scand J Gastroenterol (1999) 0.90
An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum. J Pharm Biomed Anal (2001) 0.89
Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure. Cancer Res (1980) 0.89
Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro. Cancer Res (1983) 0.89
Adverse effects of nonsteroidal anti-inflammatory drugs on the small and large bowel. Endoscopy (1999) 0.88
Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity. Cancer Res (1983) 0.86
Levels of thymidylate synthetase during normal culture growth of L1210 cells. Cancer Res (1986) 0.86
Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin. Cancer Chemother Pharmacol (1985) 0.85
Use of periodate and methylamine for the quantitation of intracellular 5-fluoro-2'-deoxyuridine-5'-monophosphate by high-performance liquid chromatography. J Chromatogr (1981) 0.85
Endoscopic therapy of adenomas of the papilla of Vater. A retrospective analysis with long-term follow-up. Dig Liver Dis (2000) 0.84
Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer. Cancer Res (1982) 0.84
Root substance removal with Er:YAG laser radiation at different parameters using a new delivery system. J Periodontol (2000) 0.84
Downregulation of ileal bile acid absorption in bile-duct-ligated rats. J Hepatol (2000) 0.84
The role of serum liver enzymes in the diagnosis of choledocholithiasis. Hepatogastroenterology (2001) 0.83
The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Mod Pathol (1994) 0.83
Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites. Cancer Treat Rep (1977) 0.83
Factors influencing the career choices of physicians trained at Yale-New Haven Hospital from 1929 through 1994. Acad Med (1998) 0.83
Molecular lesions involved in the progression of a human breast cancer. Oncogene (1988) 0.82
Impaired response to pneumococcal vaccine in Hodgkin's disease. N Engl J Med (1978) 0.82
Accelerated schedule of hepatitis B vaccination in liver transplant candidates. Transplant Proc (1998) 0.82
Who will determine the future of academic medicine? Clin Res (1986) 0.82
Influence of cholestasis on absorption of ursodeoxycholic acid. Dig Dis Sci (1999) 0.81
Pulmonary metastases in ovarian cancer. Analysis of 357 patients. Cancer (1985) 0.81
High-quality Si3N4 circuits as a platform for graphene-based nanophotonic devices. Opt Express (2013) 0.80
Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines. J Clin Invest (1980) 0.80
Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells. J Clin Invest (1979) 0.80
Early and late events in the development of human breast cancer. Basic Life Sci (1991) 0.79
First case of isolated small bowel transplantation at the university of cologne: rejection-free course under quadruple immunosuppression and endoluminal monitoring with video-capsule. Transplant Proc (2004) 0.79
5'-Deoxy-5-fluorouridine selective toxicity for human tumor cells compared to human bone marrow. Cancer Res (1983) 0.79
The presence of phospholipase A and lysophospholipase activities in culture supernatant fluid from Alteromonas espejiana. Int J Biochem (1983) 0.78
Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin. Biochim Biophys Acta (1980) 0.78
[Laparoscopic tumor staging in gastrointestinal carcinomas: significance of internal medicine laparoscopy]. Z Gastroenterol (2001) 0.78
Sclerosing variants of follicular center cell lymphomas presenting in the retroperitoneum. Cancer (1983) 0.78
Use of high-dose oral methotrexate sequenced at 24 hours with 5-FU: a clinical toxicity study. Cancer Treat Rep (1983) 0.78
Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA. Cancer Res (1983) 0.78
[Various physical parameters of toothbrushing and their relation to the appearance of non-inflammatory gingival recession]. ZWR (1987) 0.78
Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts. Cancer Res (1980) 0.77
Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma. Cancer Chemother Pharmacol (1984) 0.77
[Schonlein-Henoch syndrome with severe abdominal involvement in an adult]. Dtsch Med Wochenschr (1996) 0.77
Modulation of fluoropyrimidine metabolism in L1210 cells by L-alanosine. Biochem Pharmacol (1983) 0.77
Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response. Cancer Res (1985) 0.77
Biochemical alterations during unperturbed suspension growth of L1210 cells. Cancer Res (1981) 0.76
Randomized study comparing chemotherapy with and without estrogen priming in advanced breast-cancer. Int J Oncol (1994) 0.76
Minilaparoscopy versus conventional laparoscopy in the diagnosis of hepatic diseases. Gastrointest Endosc (2001) 0.76
[Severe complications in diagnostic laparoscopy. 9 years experience in 747 examinations]. Med Klin (Munich) (1996) 0.76
Mechanism of hepatoprotective action of bile salts in liver disease. Gastroenterol Clin North Am (1999) 0.76
Synthesis and in vitro characterization of novel amino terminally modified oxotremorine derivatives for brain muscarinic receptors. J Med Chem (1992) 0.76
Modulation of fluoropyrimidine metabolism by chlorpromazine. Biochem Biophys Res Commun (1986) 0.76
Endoscopic stenting in obstructive jaundice due to liver metastases: does it have a benefit for the patient? Hepatogastroenterology (1997) 0.76
[Percutaneous transhepatic cholangioscopy (PTCS)--an important supplement in diagnosis and therapy of biliary tract diseases (indications, technique and results)]. Z Gastroenterol (1995) 0.76
Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer. Cancer (1981) 0.76
A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma. J Clin Oncol (1984) 0.76
Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells. Cancer Res (1978) 0.76
[Endoscopic laser lithotripsy for difficult calculi after unsuccessful extracorporeal shock wave lithotripsy]. Arq Gastroenterol (1997) 0.76
[RadioVisioGraphie--system for film-free intraoral radiographs]. Dtsch Zahnarztl Z (1989) 0.75
One-year clinical evaluation of composite fillings and inlays in posterior teeth. Clin Oral Investig (1997) 0.75